SFES — Safeguard Scientifics Income Statement
0.000.00%
Last trade - 00:00- $16.37m
- $6.87m
- 32
- 49
- 77
- 52
Annual income statement for Safeguard Scientifics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 13 | 29.5 | 18.5 | 7.28 | 4.68 |
| Operating Profit | -13 | -29.5 | -18.5 | -7.28 | -4.68 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 54.6 | -37.6 | 27 | -14.3 | -9.83 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 54.6 | -37.6 | 27 | -14.3 | -9.83 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 54.6 | -37.6 | 27 | -14.3 | -9.83 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 54.6 | -37.6 | 27 | -14.3 | -9.83 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.79 | -0.734 | 1.99 | -0.671 | -0.624 |
| Special Dividends per Share |